| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2971738 | The Journal of Heart and Lung Transplantation | 2009 | 5 Pages |
Abstract
Exogenous APC administered to the donor airway attenuates ischemia-reperfusion injury after lung transplantation. This novel administration route sustains high levels of APC in the lung tissue, which should avoid frequent administration and potential systemic side effects of bleeding. Further investigation is necessary to determine the mechanism of the beneficial effect of APC in this setting.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Shin MD, Marcelo MD, Masaaki MD, Masaki MD, Patricia C. MD, Mingyao MD, Thomas K. MD, Shaf MD,